ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,249.50
-0.56%
S&P ASX All Technology
3,816.80
-0.98%
Brent Oil
73.605
-0.77%
US Dollar vs AUD
1.57403
0.21%
Bitcoin
104,670.76
0.32%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Biopharma Credit Plc (BPCP) Share Price

Biopharma Credit Plc

Biopharma Credit Plc (BPCP)

Bishop Capital Corporation New (CE)
68.80
0.00
( 0.00% )
Updated: 11:00:00
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
68.80
Bid
66.80
Offer
70.80
Volume
13,214
0.00 Day's Range 0.00
65.20 52 Week Range 76.00
Market Cap
822.079M
Previous Close
68.80
Open
-
Last Trade
724
@
69.0105
(O)
Last Trade Time
19:19:58
Financial Volume
-
VWAP
-
Average Volume (3m)
34,166
Shares Outstanding
1,194,882,668
Dividend Yield
-
PE Ratio
9.47
Earnings Per Share (EPS)
0.09
Revenue
135.74M
Net Profit
108.45M

About Biopharma Credit Plc

Sector
Finance Services
Industry
Finance Services
Headquarters
London, Ontario, Can
Founded
-
Biopharma Credit Plc is listed in the Finance Services sector of the London Stock Exchange with ticker BPCP. The last closing price for Biopharma Credit was 68.80p. Over the last year, Biopharma Credit shares have traded in a share price range of 65.20p to 76.00p.

Biopharma Credit currently has 1,194,882,668 shares in issue. The market capitalisation of Biopharma Credit is £822.08 million. Biopharma Credit has a price to earnings ratio (PE ratio) of 9.47.

Ask ADVFN Intelligence (AI)

BPCP Latest News

More News

BioPharma Credit PLC Transaction in Own Shares

BioPharma Credit PLC 24 January 2024 BioPharma Credit plc (the "Company") TRANSACTION IN OWN SHARES BioPharma Credit PLC (the "Company") announces that today it has purchased...

25 January 2024
UK Regulatory

BioPharma Credit PLC Transaction in Own Shares

BioPharma Credit PLC 23 January 2024 BioPharma Credit plc (the "Company") TRANSACTION IN OWN SHARES BioPharma Credit PLC (the "Company") announces that today it has purchased...

24 January 2024
UK Regulatory

BioPharma Credit PLC Transaction in Own Shares

BioPharma Credit PLC 22 January 2024 BioPharma Credit plc (the "Company") TRANSACTION IN OWN SHARES BioPharma Credit PLC (the "Company") announces that today it has purchased...

23 January 2024
UK Regulatory

BioPharma Credit PLC Director/PDMR Shareholding

BioPharma Credit PLC 22 January 2024 BIOPHARMA CREDIT PLC Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them 1. Details of...

22 January 2024
UK Regulatory

BioPharma Credit PLC Transaction in Own Shares

BioPharma Credit PLC 19 January 2024 BioPharma Credit plc (the "Company") TRANSACTION IN OWN SHARES BioPharma Credit PLC (the "Company") announces that today it has purchased...

20 January 2024
UK Regulatory

BioPharma Credit PLC Transaction in Own Shares

BioPharma Credit PLC 18 January 2024 BioPharma Credit plc (the "Company") TRANSACTION IN OWN SHARES BioPharma Credit PLC (the "Company") announces that today it has purchased...

19 January 2024
UK Regulatory

BioPharma Credit PLC Transaction in Own Shares

BioPharma Credit PLC 17 January 2024 BioPharma Credit plc (the "Company") TRANSACTION IN OWN SHARES BioPharma Credit PLC (the "Company") announces that today it has purchased...

18 January 2024
UK Regulatory

BioPharma Credit PLC Transaction in Own Shares

BioPharma Credit PLC 16 January 2024 BioPharma Credit plc (the "Company") TRANSACTION IN OWN SHARES BioPharma Credit PLC (the "Company") announces that today it has purchased...

17 January 2024
UK Regulatory

BioPharma Credit PLC Transaction in Own Shares

BioPharma Credit PLC 15 January 2024 BioPharma Credit plc (the "Company") TRANSACTION IN OWN SHARES BioPharma Credit PLC (the "Company") announces that today it has purchased...

16 January 2024
UK Regulatory

BioPharma Credit PLC Transaction in Own Shares

BioPharma Credit PLC 12 January 2024 BioPharma Credit plc (the "Company") TRANSACTION IN OWN SHARES BioPharma Credit PLC (the "Company") announces that today it has purchased...

13 January 2024
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.40.58479532163768.469.4682352369.06633649DE
41.52.2288261515667.371.167.23253069.34852384DE
120068.871.1663416668.0455712DE
261.92.8400597907366.974.265.22693568.32689318DE
521.42.0771513353167.47665.22108868.87072573DE
156-4.2-5.753424657537388.865.22159074.74573629DE
260-3.7-5.1034482758672.588.865.22053974.68686741DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CANCanal+ S.a
244.20p
(44,300.00%)
3.18M
INXI-nexus Global Plc
2.00p
(60.00%)
630.59k
GNIPGenip Plc
33.00p
(29.41%)
146.58k
WKSWinking Studios Limited
23.00p
(25.00%)
1.01M
QEDQuadrise Plc
4.69p
(16.09%)
6.12M
OBDOxford Biodynamics Plc
0.912p
(-24.00%)
4.84M
XLMXlmedia Plc
9.45p
(-23.79%)
7.76M
JLPJubilee Metals
3.75p
(-21.88%)
20.44M
SYMESupply@me Capital Plc
0.0028p
(-20.00%)
51.27M
PPSProton Motor Power Systems Plc
0.45p
(-18.18%)
515.92k
TRPTower Resources Plc
0.0265p
(-1.85%)
257.93M
NTVONativo Resources Plc
0.0024p
(9.09%)
255.87M
ORCPOracle Power Plc
0.03p
(-4.46%)
205.25M
ROCKRockfire Resources Plc
0.19p
(6.15%)
123.28M
VRSVersarien Plc
0.029p
(-9.38%)
95.61M

Discussion

View Full Feed
cottonmather cottonmather 3 minutes ago
moneco64. Gold/silver projections for 2025. 22 minutes https://youtu.be/bFBoFAL7ugU?si=yslJIqXex379hSoq
ramalio ramalio 3 minutes ago
Know (and appreciate) you since years as solid serious guy and expert - isn't therefore your "10/20 times multiple here" looking a bit excessive? But ok., that's just me dilettante. As you use to say: "We shall see" ...
GLTU and TIA
BTCS
ElectricMountain53 ElectricMountain53 3 minutes ago
Proto, why does he say HE's working very hard on commercial agreements when the next day he's no longer a CEO or even member of the BOD??
LWLG
uranium-pinto-beans uranium-pinto-beans 4 minutes ago
SNOW
Snowflake price target raised to $200 from $180 at Jefferies
Jefferies raised the firm's price target on Snowflake to $200 from $180 and keeps a Buy rating on the shares. The company's new product-led CEO is strengthening its artificial intelligence products, positioning it as
uranium-pinto-beans uranium-pinto-beans 5 minutes ago
AFRM
Affirm price target raised to $75 from $45 at Deutsche Bank
Deutsche Bank analyst Bryan Keane raised the firm's price target on Affirm to $75 from $45 and keeps a Hold rating on the shares after meeting with management. The company is seeing strength in spending on travel and c
AFRM
tradernewstip tradernewstip 7 minutes ago
$ILLR Releases Exclusive Video Series Showcasing Innovation and Leadership https://youtu.be/MxXnHYaYnWM?si=GFoQ8StT4NUFYAiT via
@YouTube

@jctb1

@triller_IR
ILLR
The Danish Dude The Danish Dude 8 minutes ago
The only crossover that is confounding here, is your creation of an account on X a month ago and now an account on Ihub, to counter criticism of your article. Two days ago on X you wrote thrice, that you would gladly discuss the articles content. I took you up on that, and ever since you've refused
CBOE NWBO
mdb1 mdb1 8 minutes ago
TSLA has almost gone straight up from $320s to 430s n a couple of weeks. Amazing!!!!
TSLA
funnytimes2 funnytimes2 9 minutes ago
Kraig Biocraft Laboratories Recaps Year of Breakthrough Achievements with BAM-1 Hybrids

World’s First Commercially Viable Silkworms for Recombinant Spider Silk Production

ANN ARBOR, Mich., – December 16, 2024 –Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Compan
KBLB
Golden Cross Golden Cross 10 minutes ago
🔥 $ILLR 📅 Investor Day Is Coming! 🗓️

Triller is Hosting an Exclusive Investor Day Event this
December 18th, 2024!
Time: 1:00 pm EST

⭐️ Register now: https://trillercorp.com/investor-day-registration/

https://investor
ILLR
uranium-pinto-beans uranium-pinto-beans 10 minutes ago
TSLA
Wedbush ups Tesla target by $115 with Trump 'total game changer'
Wedbush analyst Daniel Ives raised the firm's price target on Tesla to $515 from $400 and keeps an Outperform rating on the shares. The analyst believes the Trump's White House in the next four years will be a "to
TSLA
uranium-pinto-beans uranium-pinto-beans 11 minutes ago
AZO
AutoZone price target raised to $3,800 from $3,450 at TD Cowen
TD Cowen raised the firm's price target on AutoZone to $3,800 from $3,450 and keeps a Buy rating on the shares. The firm expects the company's do-it-for-me compares to reaccelerate over the coming quarters driven by
TrendTrade2016 TrendTrade2016 11 minutes ago
S&P BREAKING 6120 RESISTANCE
Golden Cross Golden Cross 11 minutes ago
🔥 $ILLR 📅 Investor Day Is Coming! 🗓️

Triller is Hosting an Exclusive Investor Day Event this
December 18th, 2024!
Time: 1:00 pm EST

⭐️ Register now: https://trillercorp.com/investor-day-registration/

https://investor
ILLR
uranium-pinto-beans uranium-pinto-beans 12 minutes ago
M
Gordon Haskett upgrades Macy's on 'very upbeat' business trends
Gordon Haskett upgraded Macy's to Buy from Hold with a $20 price target, which suggests over 20% upside from current levels. Macy's tone on current business trends "was very upbeat," which brings confidence the compan
uranium-pinto-beans uranium-pinto-beans 12 minutes ago
BKNG
Booking Holdings price target raised to $6,100 from $5,400 at JMP Securities
BKNG
PC retired PC retired 13 minutes ago
Sending power on a data cable is limited to low powers, ie mobile phones and similar devices with low power requirement. It offers no advantage other than convenience. With the low current rating involved any significant lighting array would require quite a lot of cables to power it, rather than a
FLCX
Sltan Sltan 17 minutes ago
I wonder how much the division will be with foxo
RNVA
Cameo Brien Cameo Brien 19 minutes ago
Trying a bid here
ICBU
ChangnoiPlaza ChangnoiPlaza 19 minutes ago
everyone should let chatgpt4 read and analyse the PAA
and then, if you ask the right questions, U will get interesting answers:

You are correct – if there was **no finalized book value** of the assets and liabilities at the time of the sale (September 25, 2008), the question ar
COOP
Gooddolphin Gooddolphin 20 minutes ago
NSAV Holding
@NSAV_Tech
·
32m
Despite the Grover litigation, $NSAV is looking for acquisitions in the crypto and AI spaces on a daily basis. We should be able to disclose a new AI project to you in the next day or two and a new crypto project in the next day or so. These
NSAV
Methinks Methinks 24 minutes ago
https://www.pymnts.com/cybersecurity/2024/yearlong-cyberattack-targets-security-workers/
They need to update their security systems and use Wave.
ksquared ksquared 24 minutes ago
NJ senator says feds are too ‘fearful’ of public reaction to tell the truth about mysterious drones
By Isabel Keane Published Dec. 15, 2024, 8:31 a.m. ET
(There's a Doomer Feeding Frenzy going on. If they start shooting them down...
Fall drones. Just don't fall on me.)
Methinks Methinks 27 minutes ago
https://businessday.ng/opinion/article/securing-africas-financial-sector-in-the-age-of-fintech-and-digital-banking/
Africa needs Wave - now.
DMC8 DMC8 27 minutes ago
Published: 16 December 2024
https://www.mdpi.com/2674-0311/3/4/41
AMRN

Your Recent History

LSE
BPCP
Biopharma Credit
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved